Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.50
Ask: 5.00
Change: 0.00 (0.00%)
Spread: 0.50 (11.111%)
Open: 4.75
High: 4.75
Low: 4.75
Prev. Close: 4.75
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Apr 2020 07:00

RNS Number : 0917J
Tavistock Investments PLC
08 April 2020
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Trading Update

8th April 2020

The Company is pleased to advise that its trading result for the year ended 31 March 2020 is expected to be in line with the market's expectation for continued growth in reported EBITDA.

One particular highlight of the year has been the superb performance of the Company's new range of protected UCITS funds. They were designed specifically to shield clients from the potentially disastrous consequences of sudden and sustained falls in market values, offering investors an alternative, more prudent approach to medium to long term investing.

The ACUMEN Capital Protection Portfolio and the ACUMEN ESG Protection Portfolio provide a guaranteed level of protection for investors equivalent to 90% of each fund's highest ever value (Net Asset Value or NAV). These guarantees are contractually underwritten by Morgan Stanley & Co International Plc.

By way of illustration, between 1st January and 31st March 2020, the FTSE fell 24%. By contrast, these two protected funds fell by less than 5% and 3% respectively.

As of Monday, an investment made in the ACUMEN Capital Protection Portfolio risked a maximum potential loss of only 3.6% of the initial investment, whilst still benefiting from the 90% high watermark guarantee going forward.

However, the COVID-19 pandemic has caused commercial conditions to become extremely challenging. It is inevitable that adverse economic and market performance, together with the commercial consequences of social distancing and the Government imposed lock-down, will combine to have a detrimental effect on the Company's performance in the new financial year. The impact of the pandemic will be felt for some considerable time, potentially through several iterations, and at the moment it is impossible to accurately assess the consequences.

In light of this uncertainty, the Board has adopted a number of measures to protect profitability and ensure that the business emerges from the current crises in the best working order. No dividend will be paid at the present time and a comprehensive strategic review is also being undertaken with a view to removing cost from the business. This exercise will encompass a pragmatic impairment review of the carrying value of intangible assets on the Company's Balance Sheet.

Every member of the executive team has volunteered to waive a significant proportion of their income, with immediate effect, so that everyone in the business understands that we will deal with the challenges ahead together.

Pending stability in the financial markets, the Company has withdrawn its guidance for market expectation in the year to 31 March 2021.

Brian Raven, the Company's Chief Executive, said:

"The key measure of leadership is how well it performs under difficult circumstances. Tavistock is led by a strong, experienced and unified team who have clearly demonstrated their commitment to the business and its staff.

We continue to look after the financial advice needs of our tens of thousands of underlying clients, and to manage their assets in our customary active, efficient and disciplined manner.

Market turbulence is far from over and a potentially very deep recession lies ahead.

A great many clients, particularly the less well off, cannot afford to risk further significant losses to savings or pension pots. These clients need security, ahead of investment upside potential. I believe that Tavistock's ACUMEN Protection Portfolios offer a safe haven solution for these cautious investors in these very difficult times. Whilst the funds primary purpose is to protect the downside, they will also be automatically, but gradually, reinvested from cash into higher risk assets, as market volatility reduces."

 

Ends

 

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

Arden Partners Plc

Paul Shackleton

Tel: 020 7614 5900

Allenby Capital Limited

Nick Naylor

Nick Athanas

Tel: 020 3328 5656

Vested

Elspeth Rothwell

Tel: 020 3890 8118

 

(Mobile): 07811 375 998

Amelia Graham

(Mobile): 07393 477 057

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFEFSEIDIII
Date   Source Headline
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20249:33 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSInterim Results
1st Nov 202312:25 pmRNSResult of AGM
18th Oct 20234:58 pmRNSNotice of AGM
5th Oct 20237:00 amRNSTrading update and interim dividend declaration
20th Sep 20237:00 amRNSFinal Results for Year Ended 31 March 2023
28th Apr 20235:00 pmRNSTotal Voting Rights
11th Apr 20237:00 amRNSAcquisition of Precise Protect Limited
1st Mar 20237:00 amRNSTotal Voting Rights
16th Feb 20231:45 pmRNSExercise of Options and Total Voting Rights
10th Feb 20237:00 amRNSChange of Auditor
26th Jan 20237:00 amRNSDirector appointment
20th Dec 20227:00 amRNSInterim Results
1st Dec 20227:49 amRNSSale of LEBC Hummingbird Limited
30th Nov 20225:00 pmRNSTotal Voting Rights
22nd Nov 202212:30 pmRNSBuyback shares cancelled
18th Nov 20229:30 amRNSTransaction in Own Shares
4th Nov 202211:30 amRNSExercise of Options and Total Voting Rights
31st Oct 202212:00 pmRNSResult of AGM
6th Oct 20227:00 amRNSNotice of AGM
30th Sep 20225:00 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSPosting of Annual Report and Accounts
26th Sep 20227:00 amRNSFinal Results for Year Ended 31 March 2022
2nd Sep 202212:49 pmRNSExercise of Options and Total Voting Rights
31st Aug 20225:00 pmRNSTotal Voting Rights
24th Aug 20222:14 pmRNSBuyback shares cancelled
17th Aug 202210:41 amRNSTransaction in Own Shares
16th Aug 202210:14 amRNSDirector/PDMR Shareholding
26th Jul 202211:50 amRNSDirector/PDMR Shareholding
26th Jul 202210:33 amRNSDirector/PDMR Shareholding
12th Jul 20223:42 pmRNSHolding(s) in Company
12th Jul 20221:10 pmRNSHolding(s) in Company
4th Jul 202211:56 amRNSDirector/PDMR Shareholding
30th Jun 20226:29 pmRNSTotal Voting Rights
30th Jun 20222:20 pmRNSDirector/PDMR Shareholding
29th Jun 20222:22 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update and interim dividend declaration
23rd Jun 20222:04 pmRNSExercise of Options and Total Voting Rights
23rd May 20227:00 amRNSAcquisition of LEBC Hummingbird Limited
10th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSCompletion of purchase of minority holding in LEBC
31st Mar 20225:00 pmRNSTotal Voting Rights
21st Mar 20227:00 amRNSTotal Voting Rights & AIM Rule 17
17th Mar 20227:00 amRNSHolding(s) in Company
28th Feb 202211:06 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.